Table 2.
Perlecan’s processed forms in biological tissues and fluids.
| Tissue/Fluid | Condition | Endorepellin and its fragments | Biomarker for | References |
|---|---|---|---|---|
| Murine aged gastrocnemius muscle extracts | Sarcopenia | LG1/2 | Age-related loss of skeletal muscle mass and function | [285] |
| Secretome of mast cells | Inflammation | Endorepellin and shorter forms | Inflammation | [160] |
| Secretome of endothelial cells | Apoptotic endothelial cells | LG3 and other endorepellin’s fragments | Fibrosis | [194]; [152, 283]; [299] |
| Secretome of pancreatic and colon carcinoma cells | Colon carinomas and pancreatic cancer | LG3 and other endorepellin’s fragments | High turnover rate of cancer cells | [193]; [287] |
| Secretome of neurons and neurovasculature cells | Brain infarcts | LG3 | Oxygen and glucose deprivation in neuronal cells | [281, 282] |
| Growth plate of fetal cartilage (upper zone) | Blood vessel invasion within cartilage | Endorepellin | Fetal ischemia and vascular injury | [196] |
| Amniotic fluid | Premature rupture of fetal membranes | LG3 | Fetal ischemia and vascular injury | [277]; [278] |
| Amniotic fluid | Mothers carrying Down Syndrome fetuses | LG3 | Abnormal fetal development and vascular injury | [279] |
| Urine | End-stage renal disease | LG3 | Vascular injury | [284] |
| Urine | Chronic allograft nephropathy | LG3 | Immune-mediated vascular injury | [197] |
| Urine | Children with sleep apnea | LG3 | Brain ischemia | [280] |
| Blood | Patients with refractory cytopenia with multilineage dysplasia | LG3 | Refractory cytopenia with multilineage dysplasia | [286] |
| Blood | Normal subjects and breast cancer patients | LG3 | Breast cancer | [183] |